| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 74.06B | 91.52B | 68.53B | 57.39B | 56.07B | 58.14B |
| Gross Profit | 65.25B | 74.09B | 62.44B | 55.38B | 53.53B | 55.67B |
| EBITDA | 12.20B | 21.54B | 15.06B | 10.95B | 9.52B | 12.01B |
| Net Income | 8.48B | 12.35B | 7.45B | 5.25B | 4.49B | 6.75B |
Balance Sheet | ||||||
| Total Assets | 6.76T | 6.74T | 6.65T | 6.76T | 6.61T | 7.14T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 952.16B | 1.24T | 1.80T | 1.99T | 2.80T |
| Total Debt | 221.96B | 243.53B | 222.05B | 198.94B | 182.47B | 690.05B |
| Total Liabilities | 6.56T | 6.52T | 6.46T | 6.55T | 6.42T | 6.94T |
| Stockholders Equity | 204.69B | 217.75B | 197.23B | 206.18B | 191.01B | 192.74B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 69.17B | 24.24B | 1.75B | -768.00B | 0.00 |
| Operating Cash Flow | 0.00 | 71.69B | 27.62B | 6.71B | -759.85B | 0.00 |
| Investing Cash Flow | 0.00 | -386.45B | -350.27B | -302.83B | -49.66B | -44.37B |
| Financing Cash Flow | 0.00 | 24.88B | -143.11B | -1.73B | -1.90B | 81.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥167.03B | 13.47 | ― | 2.96% | 21.41% | 42.73% | |
72 Outperform | ¥189.55B | 15.21 | ― | 2.23% | 31.23% | 66.11% | |
70 Outperform | ¥175.81B | 16.10 | 3.68% | 2.26% | 23.47% | 44.30% | |
68 Neutral | ¥155.67B | 10.44 | ― | 2.63% | 5.33% | 14.43% | |
68 Neutral | ¥187.70B | 18.03 | ― | 2.56% | 42.06% | 29.62% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥158.28B | 11.05 | ― | 2.29% | 9.41% | 45.91% |